Literature DB >> 32432759

Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3.

X Li1, H-M Yu.   

Abstract

OBJECTIVE: To clarify the role of HOXA-AS2 in the progression of diabetic nephropathy (DN) and the molecular mechanism.
MATERIALS AND METHODS: Relative levels of HOXA-AS2 and microRNA-302b-3p (miRNA-302b-3p) in serum and kidney tissues of DN rats induced by STZ administration and controls were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Serum levels of interleukin-1β (IL-1β), Transforming Growth Factor-α (TNF-α), creatinine, and BUN, as well as blood glucose in DN rats administrated with vector or pcDNA-HOXA-AS2 lentivirus, were detected. Dual-Luciferase reporter gene assay was conducted to verify the interaction among HOXA-AS2, miRNA-302b-3p, and TIMP3. At last, the regulatory effects of HOXA-AS2/miRNA-302b-3p/TIMP3 axis on levels of IL-1β and TNF-α, proliferative, and apoptotic rates in podocytes undergoing high-level glucose treatment were explored.
RESULTS: HOXA-AS2 was downregulated in STZ-induced DN rats. In vivo overexpression of HOXA-AS2 alleviated kidney injuries in DN rats, manifesting as elevations on serum levels of IL-1β, TNF-α, creatinine, BUN, and blood glucose. HOXA-AS2/miRNA-302b-3p/TIMP3 axis protected DN-induced inflammatory response, proliferation suppression, and apoptosis in podocytes following the high-glucose treatment.
CONCLUSIONS: HOXA-AS2/miRNA-302b-3p/TIMP3 axis protects inflammatory response, proliferation suppression, and apoptosis in podocytes treated with high-level glucose, thus alleviating the deterioration of DN.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32432759     DOI: 10.26355/eurrev_202005_21187

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  LncRNA HOXA-AS2 regulates microglial polarization via recruitment of PRC2 and epigenetic modification of PGC-1α expression.

Authors:  Xiaodong Yang; Yi Zhang; Yimeng Chen; Xiaoqin He; Yiwei Qian; Shaoqing Xu; Chao Gao; Chengjun Mo; Shengdi Chen; Qin Xiao
Journal:  J Neuroinflammation       Date:  2021-09-12       Impact factor: 9.587

2.  Pioglitazone Attenuates Lupus Nephritis Symptoms in Mice by Modulating miR-21-5p/TIMP3 Axis: the Key Role of the Activation of Peroxisome Proliferator-Activated Receptor-γ.

Authors:  Ding Liu; Wanzhe Zhang
Journal:  Inflammation       Date:  2021-02-18       Impact factor: 4.092

3.  MicroRNA (miR)-590-3p alleviates high-glucose induced renal tubular epithelial cell damage by targeting C-X3-C motif chemokine ligand 1 (CX3CL1) in diabetic nephropathy.

Authors:  Jie Yun; Jinyu Ren; Yufei Liu; Lijuan Dai; Liqun Song; Xiaopeng Ma; Shan Luo; Yexu Song
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

Review 4.  Long Non-Coding RNAs in the Pathogenesis of Diabetic Kidney Disease.

Authors:  Mengsi Hu; Qiqi Ma; Bing Liu; Qianhui Wang; Tingwei Zhang; Tongtong Huang; Zhimei Lv
Journal:  Front Cell Dev Biol       Date:  2022-04-20

Review 5.  TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy.

Authors:  Viviana Casagrande; Massimo Federici; Rossella Menghini
Journal:  Acta Diabetol       Date:  2021-06-28       Impact factor: 4.280

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.